Skip to content

Drug interactions

Berotralstat + Nilotinib

Severity: Major

Berotralstat and Nilotinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Berotralstat inhibits P-glycoprotein and can raise concentrations of nilotinib, which is a P-gp substrate. It also inhibits CYP3A4 and prolongs QT at higher doses, so nilotinib toxicity including QT prolongation may increase.

What this interaction means in plain words

Berotralstat and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Berotralstat belongs to Miscellaneous; Nilotinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-gp and CYP3A4 by berotralstat increases nilotinib exposure, with additive QT effects.

What to do

Obtain a baseline ECG and monitor it, along with electrolytes, during coadministration. Consider an alternative HAE prophylaxis if QTc increases.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Nilotinib?

MediHelp rates the interaction as major. Berotralstat and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Berotralstat inhibits P-glycoprotein and can raise concentrations of nilotinib, which is a P-gp substrate. It also inhibits CYP3A4 and prolongs QT at higher doses, so nilotinib toxicity including QT prolongation may increase.

How serious is the interaction between Berotralstat and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it, along with electrolytes, during coadministration. Consider an alternative HAE prophylaxis if QTc increases.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in